Drug recall: CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
FDA enforcement event 79671 is a drug recall by Coastal Meds, LLC. of Biloxi, MS, initiated 5 Apr 2018 and classified Class II, with 10 product records.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 60% of the 367 drug enforcement events initiated in 2018 carry the same class.
Status: Terminated, terminated 24 Nov 2020. Initiation: voluntary: firm initiated. This is the only enforcement event on this register for Coastal Meds, LLC..
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Coastal Meds, LLC., Biloxi, MS.
Reason for recall
"Presence of Particulate matter. Recall due to presence of unknown particulate matter."
Distribution
"Nationwide in the USA"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-0717-2018 | CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 745 vials | Class II | Terminated | 2 May 2018 |
| D-0718-2018 | ADENO-PLEX Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 200 vials | Class II | Terminated | 2 May 2018 |
| D-0719-2018 | HYDROXOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 1506 vials | Class II | Terminated | 2 May 2018 |
| D-0720-2018 | LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 3959 vials | Class II | Terminated | 2 May 2018 |
| D-0721-2018 | LIPO-DEN Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 1309 vials | Class II | Terminated | 2 May 2018 |
| D-0722-2018 | LIPO-DEN EXTREME Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 3733 vials | Class II | Terminated | 2 May 2018 |
| D-0723-2018 | LIPO-DEN PLUS Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 1457 vials | Class II | Terminated | 2 May 2018 |
| D-0724-2018 | LIPO-PLEX Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 8099 vials | Class II | Terminated | 2 May 2018 |
| D-0725-2018 | METHYLCOBALAMIN Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 4524 vials | Class II | Terminated | 2 May 2018 |
| D-0726-2018 | PYRIDOXINE Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 | 635 vials | Class II | Terminated | 2 May 2018 |
Context
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Presence of Particulate matter. Recall due to presence of unknown particulate matter."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Nationwide in the USA"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 24 Nov 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.